Dr. Sudha Ramesh
Nuclear Medicine is a branch of medicine which uses radioisotopes for diagnostic imaging and therapy purpose. First used on patients over 60 years ago. Nuclear Medicine is part of the hospital’s constant effort to update its services and offer the latest medical technology at economical rates to the needy. The hospital has sophisticated latest generation SPECT gamma camera, PET-CT and therapy wards which constitute backbone of the Department of Nuclear Medicine and PET–CT.
General Nuclear Medicine scans (Gamma/SPECT)
- Thyroid Scan
- Parathyroid Scan
- Myocardial Perfusion Scan
- Hepatobiliary Scan (HIDA)
- LUNG Scan (V/Q)
- Milk Scan (GER)
- Gastric Emptying Study
- Gastrointestinal Bleed
- Meckel’s Scan
- Renal Scan (DTPA, EC, DMSA, DRCG)
- Liver-Spleen Scan
- Bone Scan
- Sentinel Lymph Node Imaging
- Neurology (Epilepsy, Parkinson’s Disease)
- 18F-FDG – oncology (diagnosis, staging, restaging, response to therapy, follow up) and non-oncology (granulomatous disease, vasculitis, cardiac viability etc)
- 18F – DOTATATE/NOC- neural crest derived tumours (NET, MCT, PGL, Pheo, neuroblastoma, TIO etc)
- 18F– FAPI – excellent tracer for most of the malignancies.
- 68Ga – EXENDIN- insulinoma
- 18F – PSMA- prostate cancer (diagnosis, staging, restaging, response to therapy, follow up)
- High dose I-131 for treatment of differentiated thyroid carcinoma.
- Low dose I-131 for treatment of thyrotoxicosis – Graves’ disease, Toxic MNG, AFTN
- Peptide receptor radionuclide therapy (PRRT) for patients with Metastatic Neuroendocrine Tumor, TENIS (thyroglobulin elevated negative iodine scintigraphy), MCT
- PSMA radioligand therapy for patients with metastatic castration resistant prostate carcinoma
- Palliative bone pain therapy.
- I-131 MIBG therapy for malignant pheochromocytoma, metastatic neuroblastoma, paraganglioma, MCT
- Radiosynovectomy-chronically inflamed joints, refractory to treatment
- TARE-Treatment of primary and secondary hepatic malignancies